Lee Garner

发表

A polymorphism in a phosphotyrosine signalling motif of CD229 (Ly9, SLAMF3) alters SH2 domain binding and T‐cell activation

Marion H. Brown, T. Wilson, Lee I. Garner, 2015, Immunology.

Fine Specificity and Molecular Competition in SLAM Family Receptor Signalling

Marion H. Brown, T. Wilson, C. Metcalfe, 2014, PloS one.

HLA class I signal peptide polymorphism determines the level of CD94/NKG2–HLA-E-mediated regulation of effector cell responses

A. McMichael, V. Naranbhai, Mathias Viard, 2023, Nature Immunology.

Structural and molecular studies of group II leukocyte immunoglobulin-like receptors

Lee I. Garner, Lee Garner, 2011 .

Virus-specific cytotoxic T lymphocytes differentially express cell-surface leukocyte immunoglobulin-like receptor-1, an inhibitory receptor for class I major histocompatibility complex molecules.

P. Moss, N. Khan, A. Rickinson, 2005, The Journal of infectious diseases.

Crystal Structure of Leukocyte Ig-like Receptor LILRB4 (ILT3/LIR-5/CD85k)

G. Gao, J. Qi, Jinghua Yan, 2011, The Journal of Biological Chemistry.

Expression, purification, and refolding of the myeloid inhibitory receptor leukocyte immunoglobulin-like receptor-5 for structural and ligand identification studies.

B. Willcox, Lee I. Garner, M. Salim, 2006, Protein expression and purification.

Functional evolution of IGF2:IGF2R domain 11 binding generates novel structural interactions and a specific IGF2 antagonist

A. B. Hassan, F. Buffa, Rory Maclean, 2016, Proceedings of the National Academy of Sciences.

Structures of CD6 and Its Ligand CD166 Give Insight into Their Interaction

C. Robinson, Steven Johnson, S. Lea, 2015, Structure.

HLA-E–restricted SARS-CoV-2–specific T cells from convalescent COVID-19 patients suppress virus replication despite HLA class Ia down-regulation

P. Klenerman, A. McMichael, P. Borrow, 2023, Science Immunology.

Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptides

L. Hassman, A. McMichael, D. Chudakov, 2022, Nature.

High-throughput characterization of HLA-E-presented CD94/NKG2x ligands reveals peptides which modulate NK cell activation

A. McMichael, M. Birnbaum, Brooke D. Huisman, 2023, Nature communications.

An unbiased characterization of the HLA-E and CD94/NKG2x peptide repertoire reveals peptide ligands that skew NK cell activation

A. McMichael, M. Birnbaum, Brooke D. Huisman, 2022, bioRxiv.

Rational design and characterization of platelet factor 4 antagonists for the study of heparin-induced thrombocytopenia.

S. Watson, D. Cines, J. Rux, 2012, Blood.

T cell renaissance in COVID-19

L. Cifuentes, Lee Garner, 2020, Nature reviews. Immunology.